Eplerenone

High Blood Pressure

Eplerenone is used to treat hypertension (high blood pressure). It may be prescribed alone or in combination with other blood pressure medications. Lowering high blood pressure helps reduce the risk of serious cardiovascular events, such as:

• Strokes
• Heart attacks
• Kidney problems

Heart Failure After a Heart Attack

This medication is also used to treat congestive heart failure in patients who have recently experienced a heart attack. In these cases, eplerenone is typically used to improve survival rates and reduce the need for hospitalization due to worsening heart failure symptoms.

How It Works

Eplerenone belongs to a class of drugs known as aldosterone antagonists. It works by blocking the action of aldosterone, a hormone in the body that causes salt and water retention. By blocking this hormone, the medication helps the kidneys remove excess salt and water through urine while helping the body retain potassium.

Blocking Aldosterone

Eplerenone belongs to a class of medications called aldosterone receptor antagonists. It works by binding to specific sites in the body to block the action of aldosterone, a hormone that regulates salt and water balance.

Kidney Function and Fluid Balance

Aldosterone normally signals the kidneys to hold onto sodium (salt) and water while excreting potassium. When eplerenone blocks this hormone, the kidneys are able to:

• Increase the amount of salt and water passed out of the body through urine.
• Keep more potassium in the blood, which is why the drug is often called a potassium-sparing diuretic.

Effects on Blood Pressure and the Heart

By helping the body eliminate excess fluid, eplerenone reduces the total volume of blood that the heart has to pump. This lower volume results in decreased blood pressure and less physical stress on the heart muscle, which is particularly important for patients with heart failure or those recovering from a heart attack.

Common Side Effects

Many people using eplerenone do not experience serious side effects. Common issues reported include:

• Dizziness or lightheadedness
• Headache
• Diarrhea or stomach pain
• Cough
• Fatigue
• Flu-like symptoms

Serious Side Effects

The most serious side effect of eplerenone is high potassium levels in the blood (hyperkalemia). This condition can be dangerous if not monitored. Contact a doctor immediately if you notice signs of high potassium, such as:

• Muscle weakness or cramps
• Slow, fast, or irregular heartbeat
• Nausea
• Numbness or tingling sensations

Other serious side effects that require medical attention include:

• Breast tenderness or enlargement in men
• Unusual vaginal bleeding
• Swelling of the face, throat, tongue, lips, or extremities
• Difficulty breathing or swallowing
• Signs of kidney problems, such as changes in the amount of urine

High Potassium (Hyperkalemia)

The most significant risk associated with eplerenone is hyperkalemia, or excessively high levels of potassium in the blood. Severe hyperkalemia can cause fatal heart rhythm disturbances. The risk of developing this condition is higher for individuals who:

• Have kidney disease or decreased kidney function.
• Have type 2 diabetes with protein in the urine (albuminuria).
• Are taking other medications that increase potassium, such as ACE inhibitors, angiotensin receptor blockers (ARBs), or potassium supplements.
• Are elderly, as kidney function often declines with age.

Contraindications

Eplerenone is not suitable for everyone. It should not be used by people who have:

• High blood potassium levels at the start of treatment.
• Severe kidney impairment.
• Severe liver disease.

It is also contraindicated for use with strong CYP3A4 inhibitors, which are medications that prevent the body from breaking down eplerenone. Examples include certain antifungals (ketoconazole, itraconazole) and certain antibiotics (clarithromycin, telithromycin).

Monitoring and Dose Adjustments

Regular blood tests are necessary to monitor potassium levels and kidney function. These tests are typically performed before starting the medication, during the first week of treatment, one month after starting or changing the dose, and periodically thereafter. The dose may be reduced or treatment may be interrupted if potassium levels become too high.

Drug Interactions

Several types of medications can interact with eplerenone, potentially increasing the risk of side effects or reducing effectiveness:

• Moderate CYP3A4 Inhibitors: Drugs such as erythromycin, verapamil, and fluconazole can increase eplerenone levels, usually requiring a lower starting dose.
• NSAIDs: Nonsteroidal anti-inflammatory drugs (like ibuprofen or naproxen) may decrease the blood-pressure-lowering effect of eplerenone and increase the risk of kidney problems.
• Lithium: Eplerenone may increase the levels of lithium in the blood, potentially leading to toxicity.

Pregnancy

There is limited information regarding the safety of eplerenone use during pregnancy because well-controlled studies in humans have not been conducted. In animal studies, high doses of the medication did not show evidence of birth defects or other fetal harm. However, because animal results are not always representative of human outcomes, eplerenone should be used during pregnancy only when clearly needed and prescribed by a healthcare provider.

Breastfeeding

It is currently unknown whether eplerenone passes into human breast milk. Because of the potential for serious adverse reactions in a nursing infant, a decision must be made whether to stop breastfeeding or stop taking the medication. This decision should be made by weighing the importance of the medication to the mother's health against the potential risks to the infant.

Dosage Forms

Eplerenone is currently available in the following form:

• Oral Tablet: This medication is taken by mouth and is typically prescribed for daily use.

FDA Approval and Indications

Eplerenone received its initial approval from the U.S. Food and Drug Administration (FDA) in 2002. It is currently approved for the following clinical uses:

• Hypertension: For the treatment of high blood pressure, either as a standalone therapy or in combination with other medications.
• Heart Failure Post-Myocardial Infarction: To improve the survival of stable patients who show signs of heart failure and reduced heart function (left ventricular systolic dysfunction) after a recent heart attack.

Regulatory Status and Safety Oversight

Eplerenone is not a controlled substance and is available only by prescription. There are currently no Boxed Warnings or Risk Evaluation and Mitigation Strategies (REMS) required for this medication. Regulatory documentation focuses on the risk of hyperkalemia (high potassium levels), which is a significant safety consideration for this class of drugs, particularly in patients with kidney impairment or those taking certain other medications.

Generic Availability

Eplerenone is available as a generic medication. Generic drugs contain the same active ingredients as brand-name versions but are typically available at a lower cost. Choosing the generic version is a common way to reduce out-of-pocket expenses for this medication.

Insurance and Medicare Coverage

Most health insurance plans and Medicare Part D programs provide coverage for generic eplerenone. The final cost to the patient depends on the specific plan's formulary, which determines the copayment or coinsurance amount. Some plans may require a deductible to be met before coverage begins.

Factors Affecting Price

Several variables can impact the retail price of eplerenone:

• Pharmacy Selection: Prices for the same prescription can vary between different retail pharmacies and mail-order services.
• Prescription Quantity: Filling a 90-day supply may sometimes result in a lower cost per tablet compared to a 30-day supply.
• Dosage Strength: The price may differ depending on whether the 25 mg or 50 mg tablets are prescribed.

Patients are encouraged to consult with their pharmacist or insurance provider to determine the most accurate cost based on their specific coverage and location.